CNCR
Loncar Cancer Immunotherapy ETF
$13.97
0.43 (3.18%)
Currency in USD / Last Updated: 7/9/2024
| Category | Health |
|---|---|
| Market Cap | 14.4M |
| 52 Week High | 17.84 |
| 52 Week Low | 9.24 |
Customize MutualFund.com
Log in or sign up to get started.
Expense Details
| Deferred | 0 |
|---|---|
| 12b-1 | 0 |
| Front Load | 0 |
| Initial Purchase Amount | 0 |
| Redeption Fee | 0 |
| Prospectus | 0.0079 |
Overview
| 52 Week High | 17.84 |
|---|---|
| 52 Week Low | 9.24 |
| Market Cap | 14.40M |
| Shares Outstanding | 1.03M |
| Income Dividend Yield | 0.00% |
| Long Term Dividend Yield | 0.00% |
| Short Term Dividend Yield | 0.00% |
| 52 Week Yield (All) | 0.00% |
Returns Annualized
| One Day | 9999.99% |
|---|---|
| Five Days | 198.98% |
| One Months | -38.56% |
| Three Months | -42.42% |
| Six Months | -4.23% |
| Nine Months | 47.18% |
| One Year | 9.41% |
| Three Years | -21.81% |
| Five Years | -6.24% |
| Ten Years | -999 |
| YTD | 7.33% |
| Since Inception | -5.21% |
Returns Total
| One Day | 3.18% |
|---|---|
| Five Days | 2.19% |
| One Month | -3.79% |
| Three Months | -12.69% |
| Six Months | -2.10% |
| Nine Months | 33.17% |
| One Year | 9.40% |
| Three Years | -52.01% |
| Five Years | -27.50% |
| Ten Years | -999 |
| YTD | 3.71% |
| Since Inception | -37.26% |
Yearly Returns
| 2024 | 3.71% |
|---|---|
| 2023 | -1.89% |
| 2022 | -42.31% |
| 2021 | -19.15% |
| 2020 | 38.95% |
| 2019 | 24.22% |
| 2018 | -20.65% |
| 2017 | 13.61% |
| 2016 | -25.63% |
| 2015 | 14.25% |
Risk against SP-DA
| Alpha | -29.97% |
|---|---|
| Beta | 1.46 |
| Correlation | 48.58% |
| Downside Deviation | 7.81% |
| Coefficient of determination | 23.60% |
| Standard Deviation | 9.65% |
| Sharpe Ratio | -0.58 |
| Sortino | -2.47 |
| Treynor | 2.76 |
| Ulcer Index | 14.68 |
| Ulcer Performance Index | -1.31 |